Biotechnology

SUNDAY, December 5 HealthDay News)--June therapy use, researchers report that German géré '' correct '' a young for Wiskott-Aldrich Syndrome, a rare but disability katastwofik children leads to bleeding extension of hits you have minor scrapes, and let these children susceptible to certain cancers and dangerous infection. However, one in 10 children in the study developed acute T-cell leukemia, apparently as a result of living vecteur used to young healthy: the boy is currently on chemotherapy, study author. '' This is a very interesting isn't the first, but a little afraid and we need to move to plus vecteurs, '' said Dr. Mary Ellen Conley, program director genetic Immunodeficiencies in hospital St. Jude children's research in Memphis, Tenn. "The study shows evidence-two-a set of rules, which is young and stem cells therapy in a genetic disability like that great, '' added Paul Sanberg, a specialist stem cell Director for the Unive...

SUNDAY, December 5, HealthDay News)--using a gene therapy, German researchers are managed in a "fix" a report on the failure of a gene that is responsible for the Wiskott-Aldrich Syndrome, a rare but devastating childhood disorder, which leads to even very small amounts of hits or scrapes prolonged bleeding, and also to exclude those children of certain cancers and dangerous infections. However, one study, 10 children developed acute T-cell leukemia viral vector, apparently that was used to Add healthy, on account of a gene. The boy is currently the chemotherapy, research the authors note. "This is very good, first of all, but is a little bit scary and we have moved to safer and healthier the working environment, vectors," said Dr. Mary Ellen Conley, the program's Genetic Immunodeficiencies St. Jude children's Research hospital, Memphis, Tenn. the Director shall "The study shows proof of principle, such as gene therapy, genetic are in that regard with ...